back to cluster viewer
cluster path 1110100111100001
65 words, 13,012 tokens
freq alpha suffix
Words in frequency order
1 | affected | 12,727
|
2 | innervated | 57
|
3 | troubled | 46
|
4 | bitten | 31
|
5 | outnumbered | 25
|
6 | incapacitated | 24
|
7 | amputated | 18
|
8 | 'nil | 7
|
9 | stung | 5
|
10 | acidemic | 4
|
11 | ala-treated | 4
|
12 | inconvenienced | 3
|
13 | 30,400 | 2
|
14 | 3729 | 2
|
15 | 6582 | 2
|
16 | cm05 | 2
|
17 | condemns | 2
|
18 | damage/losses | 2
|
19 | ornamented | 2
|
20 | re-epithelialised | 2
|
21 | 1st-d. | 1
|
22 | 3-carbons | 1
|
23 | 4400-27,000 | 1
|
24 | aerp400 | 1
|
25 | anaemia-ans | 1
|
26 | annilihated | 1
|
27 | aorta-uncorrected | 1
|
28 | baseline-abstinent | 1
|
29 | caseine | 1
|
30 | cf3-reagent | 1
|
31 | crusts/debris | 1
|
32 | cryo-probe | 1
|
33 | cv200 | 1
|
34 | deemphasizes | 1
|
35 | dialysers-defined | 1
|
36 | dialysis-obtained | 1
|
37 | dyspareunie | 1
|
38 | echosclerotherapy | 1
|
39 | enantiodifferentiation | 1
|
40 | entangling | 1
|
41 | ff/ff | 1
|
42 | glycine/nmdar | 1
|
43 | ha-production | 1
|
44 | halo-caps | 1
|
45 | healing-mode | 1
|
46 | hypoechogenous | 1
|
47 | immuno-biochemical | 1
|
48 | intimidated | 1
|
49 | mass-market | 1
|
50 | mode-field-diameter | 1
|
51 | monthssuccess | 1
|
52 | nonrecognition | 1
|
53 | pentafluorides | 1
|
54 | post-injuries | 1
|
55 | pre-pet/ct | 1
|
56 | pre-trna | 1
|
57 | promotion-oriented- | 1
|
58 | reduced/postponed | 1
|
59 | sametime | 1
|
60 | subcategorised | 1
|
61 | treatment-intense | 1
|
62 | visumax-treated | 1
|
63 | w-pouch | 1
|
64 | w/st | 1
|
65 | well-kept | 1
|
Words in alphabetical order
1 | 'nil | 7
|
2 | 1st-d. | 1
|
3 | 3-carbons | 1
|
4 | 30,400 | 2
|
5 | 3729 | 2
|
6 | 4400-27,000 | 1
|
7 | 6582 | 2
|
8 | acidemic | 4
|
9 | aerp400 | 1
|
10 | affected | 12,727
|
11 | ala-treated | 4
|
12 | amputated | 18
|
13 | anaemia-ans | 1
|
14 | annilihated | 1
|
15 | aorta-uncorrected | 1
|
16 | baseline-abstinent | 1
|
17 | bitten | 31
|
18 | caseine | 1
|
19 | cf3-reagent | 1
|
20 | cm05 | 2
|
21 | condemns | 2
|
22 | crusts/debris | 1
|
23 | cryo-probe | 1
|
24 | cv200 | 1
|
25 | damage/losses | 2
|
26 | deemphasizes | 1
|
27 | dialysers-defined | 1
|
28 | dialysis-obtained | 1
|
29 | dyspareunie | 1
|
30 | echosclerotherapy | 1
|
31 | enantiodifferentiation | 1
|
32 | entangling | 1
|
33 | ff/ff | 1
|
34 | glycine/nmdar | 1
|
35 | ha-production | 1
|
36 | halo-caps | 1
|
37 | healing-mode | 1
|
38 | hypoechogenous | 1
|
39 | immuno-biochemical | 1
|
40 | incapacitated | 24
|
41 | inconvenienced | 3
|
42 | innervated | 57
|
43 | intimidated | 1
|
44 | mass-market | 1
|
45 | mode-field-diameter | 1
|
46 | monthssuccess | 1
|
47 | nonrecognition | 1
|
48 | ornamented | 2
|
49 | outnumbered | 25
|
50 | pentafluorides | 1
|
51 | post-injuries | 1
|
52 | pre-pet/ct | 1
|
53 | pre-trna | 1
|
54 | promotion-oriented- | 1
|
55 | re-epithelialised | 2
|
56 | reduced/postponed | 1
|
57 | sametime | 1
|
58 | stung | 5
|
59 | subcategorised | 1
|
60 | treatment-intense | 1
|
61 | troubled | 46
|
62 | visumax-treated | 1
|
63 | w-pouch | 1
|
64 | w/st | 1
|
65 | well-kept | 1
|
Words in suffix order
1 | promotion-oriented- | 1
|
2 | 1st-d. | 1
|
3 | 4400-27,000 | 1
|
4 | cv200 | 1
|
5 | 30,400 | 2
|
6 | aerp400 | 1
|
7 | 6582 | 2
|
8 | cm05 | 2
|
9 | 3729 | 2
|
10 | pre-trna | 1
|
11 | acidemic | 4
|
12 | inconvenienced | 3
|
13 | troubled | 46
|
14 | dialysis-obtained | 1
|
15 | dialysers-defined | 1
|
16 | reduced/postponed | 1
|
17 | outnumbered | 25
|
18 | re-epithelialised | 2
|
19 | subcategorised | 1
|
20 | intimidated | 1
|
21 | ala-treated | 4
|
22 | visumax-treated | 1
|
23 | annilihated | 1
|
24 | incapacitated | 24
|
25 | amputated | 18
|
26 | innervated | 57
|
27 | affected | 12,727
|
28 | aorta-uncorrected | 1
|
29 | ornamented | 2
|
30 | cryo-probe | 1
|
31 | healing-mode | 1
|
32 | dyspareunie | 1
|
33 | sametime | 1
|
34 | caseine | 1
|
35 | treatment-intense | 1
|
36 | ff/ff | 1
|
37 | entangling | 1
|
38 | stung | 5
|
39 | w-pouch | 1
|
40 | immuno-biochemical | 1
|
41 | 'nil | 7
|
42 | bitten | 31
|
43 | enantiodifferentiation | 1
|
44 | ha-production | 1
|
45 | nonrecognition | 1
|
46 | glycine/nmdar | 1
|
47 | mode-field-diameter | 1
|
48 | pentafluorides | 1
|
49 | post-injuries | 1
|
50 | damage/losses | 2
|
51 | deemphasizes | 1
|
52 | crusts/debris | 1
|
53 | anaemia-ans | 1
|
54 | condemns | 2
|
55 | 3-carbons | 1
|
56 | halo-caps | 1
|
57 | monthssuccess | 1
|
58 | hypoechogenous | 1
|
59 | pre-pet/ct | 1
|
60 | mass-market | 1
|
61 | cf3-reagent | 1
|
62 | baseline-abstinent | 1
|
63 | well-kept | 1
|
64 | w/st | 1
|
65 | echosclerotherapy | 1
|